510(k) K946146

CARDIOSPEX(TM) LIQUID CKMB/LD-1 IMMUNOINHIBITION by Clinical Controls, Inc. — Product Code JJT

K946146 is an FDA 510(k) premarket notification submitted by Clinical Controls, Inc. for the device "CARDIOSPEX(TM) LIQUID CKMB/LD-1 IMMUNOINHIBITION". The FDA issued a decision of Substantially Equivalent on January 24, 1995. The device falls under product code JJT (Enzyme Controls (Assayed And Unassayed)), a Class I device regulated under 21 CFR 862.1660. Clinical Controls, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 24, 1995
Date Received
December 16, 1994
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Controls (Assayed And Unassayed)
Device Class
Class I
Regulation Number
862.1660
Review Panel
CH
Submission Type